The Study of NSD2 Biochemical and Biological Activity Through Small-Molecule Profiling of Cell Lines
Abstract
Histone methyltransferase NSD2 (WHSC1/MMSET) is correlated with several cancers, but promising NSD2 inhibitors are yet to be developed for the clinic, alternative strategies should be studied parallel to probe development in targeting NSD2-driven cancer. In this thesis, I employ traditional biochemical, cellular biology methods and small molecule profiling to study a recurrent activating mutation of NSD2, E1099K. This study sought identify orthogonal proteins that can be targeted to inhibit the growth of E1099K-NSD2 cancers. The body of work describes biochemical and cellular approaches in studying E1099K-NSD2 that revealed E1099K-NSD2 to mono- and di- methylate NSD2 native substrate of H3K36, leading to transcriptional signatures similar to cell lines with overexpression of NSD2. To identify NSD2 E1099K-induced dependencies of cell lines, a panel of hematopoietic cancer cell lines, were profiled against a set of small molecules to establish cell viability in response to treatment. HDAC 1/2 inhibitors, were identified to have greater potency for killing E1099K- compared to WT-NSD2 cell lines. CRISPR technology was applied to engineer isogenic cell lines with different NSD2 genomic status and profiled them against the set of small-molecules. RNA-seq identified oncogenic pathway and PRC2 targets to be upregulated in E1099K-NSD2 clones. Further analysis of clones revealed a small molecule study on mycoplasma colonized cells that resulted in a brief study descibed at the end of the thesis.Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:37944987
Collections
- FAS Theses and Dissertations [6136]
Contact administrator regarding this item (to report mistakes or request changes)